The legacy of Viagra and the medicinal industry presents a intricate picture for prospective investors. Initially, copyright's hugely successful drug transformed the treatment of erectile dysfunction, producing significant profits and defining the contemporary pharmaceutical landscape. However, exclusive rights expiration and the rise of off-brand